Yu et al found that patients with POTS had significantly higher autoantibody activity to the angiotensin II type 1 receptor, even when the serum levels were similar in the POTS patient group and the control group [7]. This evidence concerns the gene AGTR1 and postural orthostatic tachycardia syndrome.